Large gap with delayed quotes
Analysis date: 12.12.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 21.11.2025.
Interest
Very weak
Very weak
One star since 05.12.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 05.12.2025 at a price of 14.52.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 04.11.2025.
4wk Rel Perf
-12.45%
-12.45%
The four-week dividend-adjusted underperformance versus SP500 is 12.45%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.61%.
Mkt Cap in $bn
5.09
5.09
With a market capitalization between $2 & $8bn, SENTINELONE INC is considered a mid-cap stock.
G/PE Ratio
1.37
1.37
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
37.47
37.47
The estimated PE is for the year 2028.
LT Growth
51.33%
51.33%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
31
31
Over the last seven weeks, an average of 31 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
124
124
For 1% of index variation, the stock varies on average by 1.24%.
Correlation
0.53
0.53
53.09% of stock movements are explained by index variations.
Value at Risk
3.74
3.74
The value at risk is estimated at USD 3.74. The risk is therefore 24.83%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
28.09.2021
28.09.2021